Viemed Healthcare, Inc. (NASDAQ:VMD) Shares Sold by Wasatch Advisors LP

Wasatch Advisors LP cut its holdings in Viemed Healthcare, Inc. (NASDAQ:VMD - Free Report) by 28.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,327,688 shares of the company's stock after selling 521,196 shares during the quarter. Wasatch Advisors LP owned approximately 3.41% of Viemed Healthcare worth $10,648,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. National Bank of Canada FI lifted its stake in shares of Viemed Healthcare by 91.2% during the 3rd quarter. National Bank of Canada FI now owns 3,346 shares of the company's stock worth $25,000 after purchasing an additional 1,596 shares during the last quarter. R Squared Ltd bought a new position in Viemed Healthcare in the fourth quarter worth about $41,000. EntryPoint Capital LLC purchased a new stake in shares of Viemed Healthcare during the fourth quarter valued at about $92,000. Prudential Financial Inc. bought a new stake in shares of Viemed Healthcare in the 4th quarter valued at about $93,000. Finally, Wells Fargo & Company MN grew its position in shares of Viemed Healthcare by 51.7% in the 4th quarter. Wells Fargo & Company MN now owns 16,024 shares of the company's stock worth $129,000 after buying an additional 5,461 shares during the last quarter. 74.24% of the stock is currently owned by institutional investors.

Viemed Healthcare Stock Up 0.9 %

Shares of NASDAQ VMD traded up $0.06 during trading hours on Friday, hitting $6.63. 183,425 shares of the stock were exchanged, compared to its average volume of 137,779. Viemed Healthcare, Inc. has a 12 month low of $6.21 and a 12 month high of $9.81. The firm has a fifty day moving average price of $7.33 and a 200-day moving average price of $8.11. The company has a quick ratio of 1.19, a current ratio of 1.31 and a debt-to-equity ratio of 0.03. The company has a market cap of $262.03 million, a PE ratio of 24.56 and a beta of 1.64.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.